SPCX has experienced a dramatic uptrend since its IPO on June 12, 2026, with a 1-year price change of +472.95%, though the stock has pulled back from its 52-week high of $225.64 to the current price of $145.30, which is 64.4% of the 52-week range. This positioning near the low end of its short trading history suggests a correction from initial euphoria, potentially offering a value entry if the uptrend resumes, but also indicating waning momentum. The 1-month price change of +561.06% reflects the IPO pop, but the stock has since declined 35.6% from its peak, signaling a volatile post-IPO adjustment. The 3-month change is identical at +561.06% due to the limited trading history, but the divergence between the 1-year trend (strongly up) and the recent 1-month decline (from the high) suggests a mean reversion or profit-taking phase. The relative strength vs. SPY is extremely high (1-month RS of 556.99), indicating the stock has vastly outperformed the market, but the recent pullback may signal a trend reversal if it continues. The 52-week low is $145.07, just below the current price of $145.30, making this a critical support level; a breakdown below $145.07 would signal further downside. The 52-week high of $225.64 represents resistance; a breakout above that level would indicate renewed bullish momentum. Beta is not provided, but the stock's 28% max drawdown and high volatility (daily swings of 5-10%) imply a beta well above 2, making it a high-risk, high-reward position.

Revenue trajectory is rapidly growing, driven by Starlink and launch services, but the company is not yet profitable. The most recent quarterly revenue is not available, but estimated revenue for the next fiscal year is $89.27 billion (average analyst estimate), implying massive scale. However, the net margin is -45.0%, and operating margin is -41.6%, indicating deep losses. The company is investing heavily in AI (xAI integration) and Starlink expansion, which is burning cash. Gross margin is 48.8%, which is healthy for aerospace, but operating expenses are high. The company is unprofitable with an EPS of -$0.67, but analysts expect positive EPS of $0.49 next year, suggesting a path to profitability. Net income is negative, so the focus is on revenue growth and margin improvement. The debt-to-equity ratio is 73.6, indicating significant leverage, and the current ratio of 1.22 suggests adequate liquidity. Free cash flow data is not provided, but the company's massive AI spending ($7.7 billion last quarter per news) and debt repayment concerns (bond market warning) point to cash flow strain. ROE is not available, but with negative net income, it would be negative. The company's financial health is precarious, relying on external financing and investor optimism to fund its growth.